Skip to main content

The impact of the recent AAP changes in palivizumab authorization on RSV-induced bronchiolitis severity and incidence

Access & Citations

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.